1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Lougheed, J.C.
Domaille, P.J.
Handel, T.M.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
J.Biomol.NMR
JBNME9
0800
0925-2738
22
211
223
10.1023/A:1014961408029
11991352
Solution structure and dynamics of melanoma inhibitory activity protein.
2002
10.2210/pdb1k0x/pdb
pdb_00001k0x
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
12258.138
Melanoma Derived Growth Regulatory Protein
1
man
polymer
MELANOMA INHIBITORY ACTIVITY
no
no
MGPMPKLADRKLCADQECSHPISMAVALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRLFWGGSVQGDYYGDLAARLGYF
PSSIVREDQTLKPGKVDVKTDKWDFYCQ
MGPMPKLADRKLCADQECSHPISMAVALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRLFWGGSVQGDYYGDLAARLGYF
PSSIVREDQTLKPGKVDVKTDKWDFYCQ
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2002-07-24
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
Crystal structure of melanoma inhibitory activity protein
Solution structure of melanoma inhibitory activity protein
The author states that an extra MET is at the
N-terminus of the sequence that is not present
in the native protein due to E. coli expression.
The residue numbering in this structure is +1
relative to 1I1J.
RCSB
Y
RCSB
2001-09-21
REL
REL
structures with the lowest energy
60
20
3D_15N-separated_NOESY
4D_13C/15N-separated_NOESY
3D_13C-separated_NOESY
4D_13C-separated_NOESY
3D_13C-separated_NOESY(centered on aromatic carbons)
HNHA
20 mM sodium acetate
4.3
ambient
298
K
Restrained molecular dynamics-simulated annealing coupled with the ambiguous restraints for iterative assignment (ARIA) extension of Nilges (M. Nilges, J. Mol. Biol. 245, 645-660, 1995).
1
lowest energy
Uniform labeling with 15N
20 mM sodium acetate-d3 pH 4.3, 0.02 % sodium azide, 10 % D2O
Uniform labeling with 13C and 15N
20 mM sodium acetate-d3 pH 4.3, 0.02 % sodium azide, 10 % D2O
Uniform labeling with 13C and 15N
20 mM sodium acetate-d3 pH 4.3, 0.02 % sodium azide, 100 % D2O
Uniform labeling with 13C and 15N
20 mM sodium acetate-d3 pH 4.3, 0.02 % sodium azide, 10 % D2O, 2.0 mM EDTA-d12
BRUNGER
refinement
X-PLOR
Brunger
structure solution
X-PLOR
3.851
P.J. Kraulis
data analysis
ANSIG
3.3
W. Boucher
processing
Azara
2.0
600
Bruker
DMX
MET
1
n
1
MET
1
A
GLY
2
n
2
GLY
2
A
PRO
3
n
3
PRO
3
A
MET
4
n
4
MET
4
A
PRO
5
n
5
PRO
5
A
LYS
6
n
6
LYS
6
A
LEU
7
n
7
LEU
7
A
ALA
8
n
8
ALA
8
A
ASP
9
n
9
ASP
9
A
ARG
10
n
10
ARG
10
A
LYS
11
n
11
LYS
11
A
LEU
12
n
12
LEU
12
A
CYS
13
n
13
CYS
13
A
ALA
14
n
14
ALA
14
A
ASP
15
n
15
ASP
15
A
GLN
16
n
16
GLN
16
A
GLU
17
n
17
GLU
17
A
CYS
18
n
18
CYS
18
A
SER
19
n
19
SER
19
A
HIS
20
n
20
HIS
20
A
PRO
21
n
21
PRO
21
A
ILE
22
n
22
ILE
22
A
SER
23
n
23
SER
23
A
MET
24
n
24
MET
24
A
ALA
25
n
25
ALA
25
A
VAL
26
n
26
VAL
26
A
ALA
27
n
27
ALA
27
A
LEU
28
n
28
LEU
28
A
GLN
29
n
29
GLN
29
A
ASP
30
n
30
ASP
30
A
TYR
31
n
31
TYR
31
A
MET
32
n
32
MET
32
A
ALA
33
n
33
ALA
33
A
PRO
34
n
34
PRO
34
A
ASP
35
n
35
ASP
35
A
CYS
36
n
36
CYS
36
A
ARG
37
n
37
ARG
37
A
PHE
38
n
38
PHE
38
A
LEU
39
n
39
LEU
39
A
THR
40
n
40
THR
40
A
ILE
41
n
41
ILE
41
A
HIS
42
n
42
HIS
42
A
ARG
43
n
43
ARG
43
A
GLY
44
n
44
GLY
44
A
GLN
45
n
45
GLN
45
A
VAL
46
n
46
VAL
46
A
VAL
47
n
47
VAL
47
A
TYR
48
n
48
TYR
48
A
VAL
49
n
49
VAL
49
A
PHE
50
n
50
PHE
50
A
SER
51
n
51
SER
51
A
LYS
52
n
52
LYS
52
A
LEU
53
n
53
LEU
53
A
LYS
54
n
54
LYS
54
A
GLY
55
n
55
GLY
55
A
ARG
56
n
56
ARG
56
A
GLY
57
n
57
GLY
57
A
ARG
58
n
58
ARG
58
A
LEU
59
n
59
LEU
59
A
PHE
60
n
60
PHE
60
A
TRP
61
n
61
TRP
61
A
GLY
62
n
62
GLY
62
A
GLY
63
n
63
GLY
63
A
SER
64
n
64
SER
64
A
VAL
65
n
65
VAL
65
A
GLN
66
n
66
GLN
66
A
GLY
67
n
67
GLY
67
A
ASP
68
n
68
ASP
68
A
TYR
69
n
69
TYR
69
A
TYR
70
n
70
TYR
70
A
GLY
71
n
71
GLY
71
A
ASP
72
n
72
ASP
72
A
LEU
73
n
73
LEU
73
A
ALA
74
n
74
ALA
74
A
ALA
75
n
75
ALA
75
A
ARG
76
n
76
ARG
76
A
LEU
77
n
77
LEU
77
A
GLY
78
n
78
GLY
78
A
TYR
79
n
79
TYR
79
A
PHE
80
n
80
PHE
80
A
PRO
81
n
81
PRO
81
A
SER
82
n
82
SER
82
A
SER
83
n
83
SER
83
A
ILE
84
n
84
ILE
84
A
VAL
85
n
85
VAL
85
A
ARG
86
n
86
ARG
86
A
GLU
87
n
87
GLU
87
A
ASP
88
n
88
ASP
88
A
GLN
89
n
89
GLN
89
A
THR
90
n
90
THR
90
A
LEU
91
n
91
LEU
91
A
LYS
92
n
92
LYS
92
A
PRO
93
n
93
PRO
93
A
GLY
94
n
94
GLY
94
A
LYS
95
n
95
LYS
95
A
VAL
96
n
96
VAL
96
A
ASP
97
n
97
ASP
97
A
VAL
98
n
98
VAL
98
A
LYS
99
n
99
LYS
99
A
THR
100
n
100
THR
100
A
ASP
101
n
101
ASP
101
A
LYS
102
n
102
LYS
102
A
TRP
103
n
103
TRP
103
A
ASP
104
n
104
ASP
104
A
PHE
105
n
105
PHE
105
A
TYR
106
n
106
TYR
106
A
CYS
107
n
107
CYS
107
A
GLN
108
n
108
GLN
108
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
LYS
11
A
N
LYS
11
A
O
VAL
98
A
O
VAL
98
A
O
PHE
80
A
O
PHE
80
A
N
TRP
61
A
N
TRP
61
A
O
SER
64
A
O
SER
64
A
N
TYR
48
A
N
TYR
48
A
O
VAL
49
A
O
VAL
49
A
N
SER
23
A
N
SER
23
A
N
MET
24
A
N
MET
24
A
O
GLN
89
A
O
GLN
89
1
A
TYR
69
-121.47
-70.09
1
A
TYR
70
35.25
44.98
1
A
ASP
72
-131.70
-91.29
1
A
LEU
73
64.93
-78.27
1
A
ALA
75
-165.67
-17.26
1
A
LEU
77
60.10
176.47
1
A
ASP
101
-121.72
-167.77
2
A
PRO
5
-49.26
151.19
2
A
ARG
56
71.17
-64.66
2
A
TYR
69
-119.54
74.84
2
A
TYR
70
-147.23
12.72
2
A
LEU
73
62.31
-86.02
2
A
ALA
75
-152.89
-40.15
2
A
LEU
77
61.73
169.33
2
A
ASP
88
-147.95
-41.92
2
A
LYS
92
-171.28
130.90
2
A
LYS
95
-142.97
33.30
3
A
TYR
70
-82.53
-129.38
3
A
ALA
74
175.08
-14.69
3
A
ASP
101
-101.57
-122.03
4
A
LEU
7
73.09
-37.96
4
A
TYR
69
-136.64
-97.78
4
A
ASP
72
-39.16
113.97
4
A
LEU
73
-146.96
-39.32
4
A
LEU
77
57.79
-179.90
4
A
ASP
88
-153.64
-30.69
5
A
ARG
56
43.88
25.02
5
A
ARG
58
52.05
-74.89
5
A
GLN
66
-79.07
-93.94
5
A
TYR
69
58.44
93.09
5
A
ASP
72
-165.33
-40.53
5
A
ARG
76
37.34
82.58
6
A
ALA
8
-115.32
-162.92
6
A
LEU
73
-153.62
-34.61
6
A
ASP
101
-102.29
-112.41
6
A
CYS
107
-105.13
52.89
7
A
LEU
7
56.39
5.31
7
A
ASP
9
-139.44
-53.04
7
A
GLN
66
-106.16
76.73
7
A
ASP
68
62.95
74.76
7
A
LEU
73
-150.73
-50.17
7
A
ALA
75
-154.68
-30.94
7
A
LEU
77
63.90
139.91
7
A
PHE
105
-148.61
58.92
8
A
ASP
9
-121.40
-52.17
8
A
GLN
66
-31.09
135.30
8
A
TYR
69
55.62
75.91
8
A
ASP
72
-148.29
35.29
8
A
LEU
73
-79.51
-73.09
8
A
ALA
75
-146.46
-43.24
8
A
LEU
77
65.94
143.59
9
A
ASP
72
56.35
80.23
9
A
LEU
73
-139.63
-50.98
9
A
ALA
74
-94.34
59.77
9
A
LEU
77
58.75
178.42
10
A
ASP
9
-131.60
-44.28
10
A
ASP
72
-152.69
-43.31
10
A
LEU
77
40.56
-157.63
11
A
LYS
54
-115.40
-133.48
11
A
ASP
68
-134.52
-45.61
11
A
TYR
69
55.88
84.38
11
A
ALA
75
-140.25
-0.42
11
A
LEU
77
56.93
104.22
11
A
TRP
103
-87.88
45.72
12
A
ASP
9
-99.26
-61.22
12
A
ASP
68
-148.00
-22.41
12
A
TYR
69
76.92
-45.74
12
A
TYR
70
57.72
16.51
12
A
LEU
73
-155.49
-46.02
13
A
LEU
7
76.42
-48.32
13
A
ASP
72
61.20
-90.25
13
A
LEU
73
62.36
-80.08
13
A
TRP
103
-94.38
56.64
13
A
ASP
104
-125.76
-51.13
13
A
PHE
105
-118.84
63.44
14
A
ALA
8
-146.61
-159.46
14
A
LYS
54
-112.18
-134.49
14
A
ASP
68
62.34
107.93
14
A
LEU
73
-151.78
-50.35
14
A
ASP
88
-146.84
-30.86
15
A
LEU
7
77.64
-46.04
15
A
GLN
66
-91.35
-85.17
15
A
TYR
69
66.85
-78.97
15
A
TYR
70
45.56
26.47
15
A
LEU
73
85.38
-47.05
15
A
ALA
74
-88.27
40.18
15
A
ASP
88
-130.08
-31.81
15
A
LYS
92
-170.97
131.01
16
A
LEU
7
78.44
-50.92
16
A
SER
19
-102.73
41.41
16
A
ASP
68
-135.97
-33.04
16
A
TYR
69
56.27
87.40
16
A
LEU
73
-143.07
-16.10
16
A
PHE
105
-151.43
47.94
17
A
ASP
9
-101.79
-61.23
17
A
ARG
56
42.54
27.86
17
A
ASP
68
78.44
78.29
17
A
TYR
69
-95.14
-83.88
17
A
ASP
72
-165.26
114.26
17
A
LEU
73
-159.89
6.22
18
A
LYS
54
-131.83
-42.25
18
A
ARG
56
58.84
19.09
18
A
GLN
66
-74.12
-78.02
18
A
ASP
68
67.88
94.11
18
A
ASP
72
-148.12
10.66
18
A
TRP
103
-88.71
48.01
19
A
LEU
7
75.44
-34.39
19
A
ASP
9
-129.68
-53.52
19
A
LEU
73
-150.17
-24.65
19
A
LYS
92
-172.55
135.01
20
A
LYS
54
-89.01
-97.26
20
A
ARG
56
74.90
-58.26
20
A
ARG
58
58.57
-77.37
20
A
LEU
73
-134.08
-57.03
20
A
TRP
103
-86.75
47.58
Solution Structure of Melanoma Inhibitory Activity Protein
1
N
N
disulf
2.032
A
CYS
13
A
SG
CYS
13
1_555
A
CYS
18
A
SG
CYS
18
1_555
disulf
2.034
A
CYS
36
A
SG
CYS
36
1_555
A
CYS
107
A
SG
CYS
107
1_555
HORMONE/GROWTH FACTOR
SH3 subdomain, HORMONE-GROWTH FACTOR COMPLEX
MIA_HUMAN
UNP
1
25
Q16674
GPMPKLADRKLCADQECSHPISMAVALQDYMAPDCRFLTIHRGQVVYVFSKLKGRGRLFWGGSVQGDYYGDLAARLGYFP
SSIVREDQTLKPGKVDVKTDKWDFYCQ
25
131
1K0X
2
108
Q16674
A
1
2
108
1
SEE REMARK 999
MET
1
1K0X
A
Q16674
UNP
1
2
5
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
ARG
10
A
ARG
10
A
CYS
13
A
CYS
13
A
VAL
96
A
VAL
96
A
LYS
99
A
LYS
99
A
GLY
78
A
GLY
78
A
PRO
81
A
PRO
81
A
PHE
60
A
PHE
60
A
GLN
66
A
GLN
66
A
VAL
46
A
VAL
46
A
LYS
52
A
LYS
52
A
SER
23
A
SER
23
A
ALA
27
A
ALA
27
A
VAL
85
A
VAL
85
A
THR
90
A
THR
90